Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose Atypical teratoid/rhabdoid tumor (ATRT) is a highly aggressive malignancy with peak incidence in children aged less than 3 years. Standard treatment for central nervous system ATRT in children under the age of 3 years have not been established yet. The objective of this study was to analyze characteristics and clinical outcomes of ATRT in children aged less than 3 years.Materials and Methods A search of medical records from seven centers was performed between January 2005 and December 2016.Results Forty-three patients were enrolled. With a median follow-up of 90 months, 27 patients (64.3%) showed at least one episode of disease progression (PD). The first date of PD was at 160 days after diagnosis. The 1- and 3-year progression-free survivals (PFS) were 51.2% and 28.5%, respectively. The 1- and 3-year overall survivals were 61.9% and 38.1%, respectively. The 3-year PFS was improved from 0% in pre-2011 to 47.4% in post-2011. Excluding one patient who did not receive any further therapy after surgery, 27 patients died due to PD (n=21), treatment-related toxicity (n=5), or unknown cause (n=1). In univariate analysis, factors associated with higher 3-year PFS were no metastases, diagnosis after 2011, early adjuvant radiotherapy, and high-dose chemotherapy (HDCT). In multivariate analysis, the use of HDCT and adjuvant radiotherapy remained significant prognostic factors for PFS (both p < 0.01).Conclusion Aggressive therapy including early adjuvant radiotherapy and HDCT could be considered to improve outcomes of ATRT in children under the age of 3 years.
Abstract
Purpose Atypical teratoid/rhabdoid tumor (ATRT) is a highly aggressive malignancy with peak incidence in children aged less than 3 years. Standard treatment for central nervous system ATRT in children under the age of 3 years have not been established yet. The objective of this study was to analyze characteristics and clinical outcomes of ATRT in children aged less than 3 years.Materials and Methods A search of medical records from seven centers was performed between January 2005 and December 2016.Results Forty-three patients were enrolled. With a median follow-up of 90 months, 27 patients (64.3%) showed at least one episode of disease progression (PD). The first date of PD was at 160 days after diagnosis. The 1- and 3-year progression-free survivals (PFS) were 51.2% and 28.5%, respectively. The 1- and 3-year overall survivals were 61.9% and 38.1%, respectively. The 3-year PFS was improved from 0% in pre-2011 to 47.4% in post-2011. Excluding one patient who did not receive any further therapy after surgery, 27 patients died due to PD (n=21), treatment-related toxicity (n=5), or unknown cause (n=1). In univariate analysis, factors associated with higher 3-year PFS were no metastases, diagnosis after 2011, early adjuvant radiotherapy, and high-dose chemotherapy (HDCT). In multivariate analysis, the use of HDCT and adjuvant radiotherapy remained significant prognostic factors for PFS (both p < 0.01).Conclusion Aggressive therapy including early adjuvant radiotherapy and HDCT could be considered to improve outcomes of ATRT in children under the age of 3 years.
참고문헌 (29)
- Hilden JM, "Central nervous system atypical teratoid", rhabdoid tumor : results of therapy in children enrolled in a registry, 2004, pp.22, 2877~2884
- Tekautz TM, "Atypical teratoid", rhabdoid tumors(ATRT) : improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy, 2005, pp.23, 1491~1499
- Woehrer A, "Incidence of atypical teratoid", rhabdoid tumors in children : a population-based study by the Austrian Brain Tumor Registry, 1996-2006, 2010, pp.116, 5725~5732
- Cohen BH, "Pilot study of intensive chemotherapy with peripheral hematopoietic cell support for children less than 3 years of age with malignant brain tumors, the CCG-99703 phase I", II study : a report from the Children’s Oncology Group, 2015, pp.53, 31~46
- Burger PC, "Atypical teratoid", rhabdoid tumor of the central nervous system : a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma : a Pediatric Oncology Group study, 1998, pp.22, 1083~1092
- Weiss E, "Treatment of primary malignant rhabdoid tumor of the brain : report of three cases and review of the literature", Int J Radiat Oncol Biol Phys, 41, pp.1013~1019 (1998)
- Mulhern RK, "Late neurocognitive sequelae in survivors of brain tumours in childhood", Lancet Oncol, 5, pp.399~408 (2004)
- Gardner SL, "Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors", Pediatr Blood Cancer, 51, pp.235~240 (2008)
- Pai Panandiker AS, "Sequencing of local therapy affects the pattern of treatment failure and survival in children with atypical teratoid rhabdoid tumors of the central nervous system", Int J Radiat Oncol Biol Phys, 82, pp.1756~1763 (2012)
- Chi SN, "Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor", J Clin Oncol, 27, pp.385~389 (2009)
- Chang CH, "An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas", Radiology, 93, pp.1351~1359 (1969)
- Rosenfeld A, "A phase II prospective study of sequential myeloablative chemotherapy with hematopoietic stem cell rescue for the treatment of selected high risk and recurrent central nervous system tumors", J Neurooncol, 97, pp.247~255 (2010)
- Chen YW, "Impact of radiotherapy for pediatric CNS atypical teratoid", rhabdoid tumor(single institute experience), 2006, pp.64, 1038~1043
- Lee JY, "Atypical teratoid", rhabdoid tumors : the need for more active therapeutic measures in younger patients, 2012, pp.107, 413~419
- 성기웅, "Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Atypical Teratoid", Rhabdoid Tumor, 2016, pp.48(4), 1408~1419[DOI]
- Zaky W, "Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid", rhabdoid tumors : the Head Start III experience, 2014, pp.61, 95~101
- Fossey M, "Atypical teratoid rhabdoid tumor in the first year of life : the Canadian ATRT registry experience and review of the literature", J Neurooncol, 132, pp.155~162 (2017)
- Reddy AT, "Efficacy of high-dose chemotherapy and three-dimensional conformal radiation for atypical teratoid", rhabdoid tumor : a report from the Children’s Oncology Group Trial ACNS0333, 2020, pp.38, 1175~1185
- Elizabeth Anne Richardson, "Atypical Teratoid Rhabdoid Tumour : From Tumours to Therapies", 대한신경외과학회지, 61(3), pp.302~311 (2018), 대한신경외과학회
- Sung KW, "Tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma", Bone Marrow Transplant, 40, pp.37~45 (2007)
- Ginn KF, "Atypical teratoid rhabdoid tumor : current therapy and future directions", Front Oncol, 2, pp.114~ (2012)
- Lafay-Cousin L, "Central nervous system atypical teratoid rhabdoid tumours : the Canadian Paediatric Brain Tumour Consortium experience", Eur J Cancer, 48, pp.353~359 (2012)
- Slavc I, "Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012", Cancer Med, 3, pp.91~100 (2014)
- Singh A, "Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors(CNS ATRT) : favorable activity of targeting EGFR-ErbB2 signaling with lapatinib", Mol Oncol, 7, pp.497~512 (2013)
- Venneti S, "p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors", J Neuropathol Exp Neurol, 70, pp.596~609 (2011)
- Athale UH, "Childhood atypical teratoid rhabdoid tumor of the central nervous system : a meta-analysis of observational studies", J Pediatr Hematol Oncol, 31, pp.651~663 (2009)
- Lafay-Cousin L, "Neurocognitive evaluation of long term survivors of atypical teratoid rhabdoid tumors(ATRT) : the Canadian registry experience", Pediatr Blood Cancer, 62, pp.1265~1269 (2015)
- Duffner PK, "Long-term consequences of CNS treatment for childhood cancer, Part II : Clinical consequences", Pediatr Neurol, 7, pp.237~242 (1991)
- Hasan A, "Treatment-related morbidity in atypical teratoid", rhabdoid tumor : multifocal necrotizing leukoencephalopathy, 2011, pp.47, 7~14